Active Ingredient(s):Infliximab-dyyb FDA Approved: * April 5, 2016 Pharm Company: *CELLTRION INC Category:Immunosuppressive
Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease. It is given by slow injection into a vein, typically at six- to eight-week intervals.
Common side effects include infections, acute infusion reacti...
* May have multiple approval dates, manufacturers, or labelers.
Inflectra 100 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution